Delivery Order SPE2DB20D2014-SPE2DB25FC56U
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,410.24 firm fixed price delivery order (SPE2DB22D3011|SPE2DB24FQ0PL) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564261717 Fenofibrate 145 mg Tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,068.36, is for the supply of 4564160110 - Fenofibrate 145 mg tablets in 90-count bottles. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,885.87 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of 500 units of 145 mg Fenofibrate tablets to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 9, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,301.09, is for the delivery of Fenofibrate 145 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through March 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,836.58, is for the delivery of Fenofibrate 145 mg tablets in quantities of 500 per bottle. The contract is a firm fixed-price delivery order with a period of performance through February 24, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,466.45, is for the delivery of Fenofibrate 145 mg tablets. It is a firm fixed-price delivery order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,453.62 firm fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,750.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 145 mg fenofibrate tablets. The order is for 100 tablets to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 4, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for a common cholesterol medication supports the Defense Logistics Agency's mission to provide critical healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of fenofibrate 145 mg tablets. The ceiling value of this order is $1,072.97. This award was not set aside for a specific business type. AmerisourceBergen is the prime contractor and no subcontractors were mentioned. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,658.44 firm-fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC56UDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,214.93 to AmerisourceBergen Drug Corp for the supply of Fenofibrate 145 mg tablets (90-count) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this order as a child order under its significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The broader IDC vehicle through which this delivery order was issued serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs, enabling AmerisourceBergen to supply a wide range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains to customers including the Defense Health Agency and the U.S. Coast Guard. The award reflects the contractor's established capability to meet federal medical procurement requirements through open competition and its critical role within the Defense Logistics Agency's medical supply chain infrastructure supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/25/25 |